JP2012025752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012025752A5 JP2012025752A5 JP2011177452A JP2011177452A JP2012025752A5 JP 2012025752 A5 JP2012025752 A5 JP 2012025752A5 JP 2011177452 A JP2011177452 A JP 2011177452A JP 2011177452 A JP2011177452 A JP 2011177452A JP 2012025752 A5 JP2012025752 A5 JP 2012025752A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- disease
- medicament
- seq
- hgf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 108010043026 HGF activator Proteins 0.000 claims 3
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims 3
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims 3
- 102100031465 Hepatocyte growth factor activator Human genes 0.000 claims 2
- 230000033115 angiogenesis Effects 0.000 claims 2
- 230000008482 dysregulation Effects 0.000 claims 2
- 230000011664 signaling Effects 0.000 claims 2
- 101001066338 Homo sapiens Hepatocyte growth factor activator Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000002860 competitive effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61565704P | 2004-10-04 | 2004-10-04 | |
| US60/615,657 | 2004-10-04 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535866A Division JP4937127B2 (ja) | 2004-10-04 | 2005-10-03 | 肝細胞成長因子活性化物質のモジュレータ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012025752A JP2012025752A (ja) | 2012-02-09 |
| JP2012025752A5 true JP2012025752A5 (OSRAM) | 2012-11-01 |
| JP5554298B2 JP5554298B2 (ja) | 2014-07-23 |
Family
ID=36148972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535866A Expired - Fee Related JP4937127B2 (ja) | 2004-10-04 | 2005-10-03 | 肝細胞成長因子活性化物質のモジュレータ |
| JP2011177452A Expired - Fee Related JP5554298B2 (ja) | 2004-10-04 | 2011-08-15 | 肝細胞成長因子活性化物質のモジュレータ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535866A Expired - Fee Related JP4937127B2 (ja) | 2004-10-04 | 2005-10-03 | 肝細胞成長因子活性化物質のモジュレータ |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20060147451A1 (OSRAM) |
| EP (1) | EP1809673B1 (OSRAM) |
| JP (2) | JP4937127B2 (OSRAM) |
| KR (1) | KR101252306B1 (OSRAM) |
| CN (1) | CN101035810B (OSRAM) |
| AU (1) | AU2005294146B2 (OSRAM) |
| BR (1) | BRPI0515670A (OSRAM) |
| CA (1) | CA2577598C (OSRAM) |
| ES (1) | ES2398528T3 (OSRAM) |
| IL (1) | IL181450A0 (OSRAM) |
| NO (1) | NO20072302L (OSRAM) |
| NZ (1) | NZ553327A (OSRAM) |
| RU (1) | RU2418004C2 (OSRAM) |
| WO (1) | WO2006042173A2 (OSRAM) |
| ZA (1) | ZA200701789B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2418004C2 (ru) | 2004-10-04 | 2011-05-10 | Дженентек, Инк. | Модуляторы активатора фактора роста гепатоцитов |
| US8088908B2 (en) * | 2005-05-10 | 2012-01-03 | City Of Hope | Humanized anti-prostate stem cell antigen monoclonal antibody |
| WO2008022746A1 (en) * | 2006-08-21 | 2008-02-28 | F. Hoffmann-La Roche Ag | Tumor therapy with an anti-vegf antibody |
| PE20081760A1 (es) | 2007-02-09 | 2009-01-01 | Genentech Inc | Anticuerpos anti-robo4 y sus usos |
| JP2012504961A (ja) | 2008-10-06 | 2012-03-01 | ミネルバ バイオテクノロジーズ コーポレーション | Ｍｕｃ１＊抗体 |
| EP2491058A1 (en) * | 2009-10-19 | 2012-08-29 | F. Hoffmann-La Roche AG | Modulators of hepatocyte growth factor activator |
| US20110206704A1 (en) * | 2009-10-19 | 2011-08-25 | Genentech, Inc. | Methods and compositions for modulating hepatocyte growth factor activator |
| KR20120105447A (ko) | 2009-10-22 | 2012-09-25 | 제넨테크, 인크. | 항-헵신 항체 및 그의 사용 방법 |
| US8772457B2 (en) | 2010-11-10 | 2014-07-08 | Genentech, Inc. | BACE1 antibodies |
| JP6859259B2 (ja) | 2014-11-19 | 2021-04-14 | ジェネンテック， インコーポレイテッド | ＢＡＣＥｌに対する抗体及び神経疾患免疫療法のためのその使用 |
| JP6993228B2 (ja) | 2014-11-19 | 2022-03-03 | ジェネンテック， インコーポレイテッド | 抗トランスフェリン受容体／抗ｂａｃｅ１多重特異性抗体および使用方法 |
| US11746159B2 (en) | 2015-02-10 | 2023-09-05 | Minerva Biotechnologies Corporation | Humanized anti-MUC1* antibodies |
| WO2023172863A1 (en) * | 2022-03-07 | 2023-09-14 | Elixiron Immunotherapeutics (hong Kong) Limited | Anti-cd36 antibodies and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0940468A1 (en) * | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| CA2102463A1 (en) * | 1992-11-05 | 1994-05-06 | Mitsubishi Chemical Corporation | Protein and gene encoding said protein |
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| JP4090236B2 (ja) * | 2000-12-05 | 2008-05-28 | 三菱化学株式会社 | 活性型肝細胞増殖因子アクティベーターに対する特異的抗体とその使用法 |
| US7045602B2 (en) * | 2000-12-05 | 2006-05-16 | Mitsubishi Chemical Corporation | Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| RU2418004C2 (ru) | 2004-10-04 | 2011-05-10 | Дженентек, Инк. | Модуляторы активатора фактора роста гепатоцитов |
-
2005
- 2005-10-03 RU RU2007116806/10A patent/RU2418004C2/ru not_active IP Right Cessation
- 2005-10-03 ZA ZA200701789A patent/ZA200701789B/xx unknown
- 2005-10-03 NZ NZ553327A patent/NZ553327A/en not_active IP Right Cessation
- 2005-10-03 EP EP05810858A patent/EP1809673B1/en not_active Expired - Lifetime
- 2005-10-03 ES ES05810858T patent/ES2398528T3/es not_active Expired - Lifetime
- 2005-10-03 CN CN2005800338036A patent/CN101035810B/zh not_active Expired - Fee Related
- 2005-10-03 JP JP2007535866A patent/JP4937127B2/ja not_active Expired - Fee Related
- 2005-10-03 US US11/242,617 patent/US20060147451A1/en not_active Abandoned
- 2005-10-03 WO PCT/US2005/036300 patent/WO2006042173A2/en not_active Ceased
- 2005-10-03 AU AU2005294146A patent/AU2005294146B2/en not_active Ceased
- 2005-10-03 KR KR1020077007643A patent/KR101252306B1/ko not_active Expired - Fee Related
- 2005-10-03 CA CA2577598A patent/CA2577598C/en not_active Expired - Fee Related
- 2005-10-03 BR BRPI0515670-0A patent/BRPI0515670A/pt not_active IP Right Cessation
-
2007
- 2007-02-20 IL IL181450A patent/IL181450A0/en unknown
- 2007-05-03 NO NO20072302A patent/NO20072302L/no not_active Application Discontinuation
-
2008
- 2008-08-01 US US12/184,969 patent/US7825221B2/en not_active Expired - Fee Related
-
2010
- 2010-09-15 US US12/883,033 patent/US8399629B2/en not_active Expired - Fee Related
-
2011
- 2011-08-15 JP JP2011177452A patent/JP5554298B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-12 US US13/765,625 patent/US8969528B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012025752A5 (OSRAM) | ||
| NZ626269A (en) | Anti-phf-tau antibodies and their uses | |
| UY33407A (es) | Anticuerpos específicos del factor gdf8 humano | |
| LTC2567976I2 (lt) | Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui | |
| HUE046222T2 (hu) | Gyermekkori akut limfoblasztos leukémia kezelése bispecifikus, CD3XCD19 elleni ellenanyagokkal | |
| MX375113B (es) | Anticuerpos que se unen específicamente a la toxina alfa de staphylococcus aureus y métodos de uso. | |
| AR096895A2 (es) | Anticuerpo que se une a la citoquina, linfopoyetina estromal tímica (tslp) | |
| DK2352763T4 (da) | Bispecifikke enkeltkædede antistoffer med specificitet for højmolekylære målantigener | |
| NZ602320A (en) | Bispecific, bivalent anti-vegf/anti-ang-2 antibodies | |
| JO3097B1 (ar) | الأجسام المضادة c-Met | |
| NZ611076A (en) | Anti-ngf compositions and use thereof | |
| UY32603A (es) | Inmunoglobulina con dominio variable dual y usos de la misma | |
| LTPA2016030I1 (lt) | Dauginės mielomos, naudojant kombinuotas terapijas, pagrįstas anti-CS1 antikūnais, gydymo būdai | |
| UY31862A (es) | Inmunoglobulina con dominio variable dual y usos de la misma | |
| NZ586053A (en) | Anti-vegf antibody compositions and methods | |
| EA201201357A1 (ru) | Антитела к cd40 | |
| EA201891833A1 (ru) | Комбинация для лечения амиотрофического бокового склероза или родственных болезней | |
| NZ599737A (en) | Il-17a antagonists | |
| UA113388C2 (xx) | ЗАСТОСУВАННЯ АНТИТІЛА ПРОТИ с-МЕТ | |
| DK2056874T3 (da) | Tumorterapi med et anti-vegf-antistof | |
| NZ599140A (en) | Antibodies that specifically bind to the epha2 receptor | |
| NL1032132A1 (nl) | Nieuwe MAdCAM-antilichamen. | |
| IN2012DN02521A (OSRAM) | ||
| EA201491151A1 (ru) | Соединения, ингибирующие металлоферменты | |
| EA200900767A1 (ru) | Антагонистические антитела против ephb3 |